| Unit price (2008A$) | Number of units | Sources and assumptions | ||
---|---|---|---|---|---|
 | Government | Patient | Year 1 | Year 2+ |  |
Pharmaceutical costs | Â | ||||
Annual cost of low-dose diuretic therapy | $52.03 | $18.79 | 1 | 1 | Average annual PBS cost for the standard daily dose [24] of hydrochlorothiazide, chlorthalidone and indapamide, weighted by scripts provided in 2008 [23]. |
Annual cost of calcium channel blocker therapy | $163.66 | $54.22 | 1 | 1 | Average annual PBS cost for the standard daily dose [24] of verapimil, amlodopine (maleate), nifedipine, felodipine, amlodopine (besylate) and lercanidipine,weighted by scripts provided in 2008 [23]. |
Annual cost of ACE inhibitor therapy | $130.85 | $81.21 | 1 | 1 | Average annual PBS cost for the standard daily dose [24] ofcaptopril, fosinopril, enalopril, ramipril, quinapril, lisinopril, trandolopril and perindopril, weighted by scripts provided in 2008 [23]. |
Annual cost of beta-blocker therapy | $169.59 | $47.09 | 1 | 1 | Average annual PBS cost for the standard daily dose [25]of fluvastatin, simvastatin, atorvastatin, pravastatin and rosuvastatin, weighted by scripts provided in 2008 [23]. |
Annual cost of statin therapy | $508.64 | $178.79 | 1 | 1 | Average annual PBS cost for the standard daily dose [25] of fluvastatin, simvastatin, atorvastatin, pravastatin and rosuvastatin, weighted by scripts provided in 2008 [23]. |
Annual cost of statin therapy in New Zealand | $18.25 | − | 1 | 1 | Average annual cost of simvastatin (40 mg/day) in New Zealand [38]. |
Annual cost of current practice lipid-lowering therapy | $559.68 | $123.37 | 1 | 1 | Average annual cost from actual PBS expenditure on lipid-lowering drugs in 2008 [23]. |
Annual cost of current practice blood pressure-lowering therapy | $169.59 | $47.09 | 1 | 1 | Average annual cost from actual PBS expenditure on bloodpressure-lowering drugs in 2008 [23]. Mix of diuretics, beta-blockers, calcium channel blockers and ACE inhibitors based on BEACH general practice data [32]. |